{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:44:22Z","timestamp":1791477862048,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Janssen Global Services, LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40121-020-00354-x","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T05:02:53Z","timestamp":1603774973000},"page":"213-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Predictors and Outcomes of Hospitalization for Influenza: Real-World Evidence from the United States Medicare Population"],"prefix":"10.1007","volume":"10","author":[{"given":"Susan C.","family":"Bolge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furaha","family":"Kariburyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Fleischhackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"354_CR1","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu): what you need to know. 2018. https:\/\/www.cdc.gov\/flu\/keyfacts.htm. Accessed Nov 21, 2018."},{"key":"354_CR2","unstructured":"World Health Organization. Fact sheets: detail: influenza (seasonal). 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal). Accessed Nov 21, 2018."},{"key":"354_CR3","unstructured":"Centers for Disease Control and Prevention. Estimated influenza illnesses, medical visits, and hospitalizations averted by vaccination in the United States. 2018. https:\/\/www.cdc.gov\/flu\/about\/disease\/2016-17.htm. Accessed Nov 21, 2018."},{"issue":"27","key":"354_CR4","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1016\/j.vaccine.2018.05.057","volume":"36","author":"WCWS Putri","year":"2018","unstructured":"Putri WCWS, Muscatello DJ, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960\u20136.","journal-title":"Vaccine"},{"issue":"2","key":"354_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40258-013-0020-6","volume":"11","author":"S Karve","year":"2013","unstructured":"Karve S, Misurski D, Herrera-Taracena G, Davis KL. Annual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database. Appl Health Econ Health Policy. 2013;11(2):119\u201328.","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"354_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3111\/13696998.2012.752376","volume":"16","author":"J Mauskopf","year":"2013","unstructured":"Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ. 2013;16(2):264\u201377.","journal-title":"J Med Econ"},{"key":"354_CR7","doi-asserted-by":"publisher","first-page":"i6258","DOI":"10.1136\/bmj.i6258","volume":"355","author":"S Ghebrehewet","year":"2016","unstructured":"Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ. 2016;355:i6258.","journal-title":"BMJ"},{"key":"354_CR8","unstructured":"Centers for Disease Control and Prevention. Who is at high risk for flu complications. 2018. https:\/\/www.cdc.gov\/flu\/about\/disease\/high_risk.htm. Accessed Nov 21, 2018."},{"key":"354_CR9","unstructured":"European Centre for Disease Prevention and Control. Risk groups for severe influenza. 2018. https:\/\/ecdc.europa.eu\/en\/seasonal-influenza\/prevention-and-control\/vaccines\/risk-groups. Accessed Nov 21, 2018."},{"issue":"2","key":"354_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3111\/13696998.2012.752376","volume":"16","author":"J Mauskopf","year":"2013","unstructured":"Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ. 2013;16(2):264\u201377.","journal-title":"J Med Econ"},{"issue":"6","key":"354_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):e1\u2013e47.","journal-title":"Clin Infect Dis"},{"key":"354_CR12","unstructured":"Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2013\u20132014. MMWR Recomm Rep. 2013;62(RR-07):1\u201343."},{"issue":"6","key":"354_CR13","doi-asserted-by":"publisher","first-page":"636.e1","DOI":"10.1016\/j.amjmed.2015.10.031","volume":"129","author":"PJ Lu","year":"2016","unstructured":"Lu PJ, O'Halloran A, Ding H, Srivastav A, Williams WW. Uptake of influenza vaccination and missed opportunities among adults with high-risk conditions, United States, 2013. Am J Med. 2016;129(6):636.e1\u201311.","journal-title":"Am J Med"},{"key":"354_CR14","unstructured":"Centers for Disease Control and Prevention. Frequently asked questions about estimated flu burden: what are seasonal-influenza-related deaths? 2018. https:\/\/www.cdc.gov\/flu\/about\/disease\/us_flu-related_deaths.htm. Accessed Nov 21, 2018."},{"issue":"1","key":"354_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","volume":"12","author":"MT Osterholm","year":"2012","unstructured":"Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36\u201344.","journal-title":"Lancet Infect Dis"},{"key":"354_CR16","unstructured":"Centers for Disease Control and Prevention. Past reasons vaccine effectiveness. https:\/\/www.cdc.gov\/flu\/vaccines-work\/past-seasons-estimates.html. Accessed June 23, 2020."},{"key":"354_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.12462","volume":"1323","author":"RG Webster","year":"2018","unstructured":"Webster RG, Govorkova EA. Continuing challenges in influenza. Ann N Y Acad Sci. 2018;1323:115\u201339.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"354_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/QCO.0000000000000496","volume":"31","author":"KR Beard","year":"2018","unstructured":"Beard KR, Brendish NJ, Clark TW. Treatment of influenza with neuraminidase inhibitors. Curr Opin Infect Dis. 2018;31(6):514\u20139.","journal-title":"Curr Opin Infect Dis"},{"key":"354_CR19","unstructured":"Accessdata.fda.gov. Highlights of prescribing information: Tamiflu. 2011. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021087s057lbl.pdf. Accessed Apr 17, 2019."},{"key":"354_CR20","unstructured":"Accessdata.fda.gov. Highlights of prescribing information: Relenza. 2010. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021036s025lbl.pdf. Accessed Apr 17, 2019."},{"key":"354_CR21","unstructured":"Accessdata.fda.gov. Highlights of prescribing information: Rapivab. 2014. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/206426lbl.pdf. Accessed Apr 17, 2019."},{"issue":"9","key":"354_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/v10090454","volume":"10","author":"C Parra-Rojas","year":"2018","unstructured":"Parra-Rojas C, Nguyen VK, Hernandez-Mejia G, Hernandez-Vargas EA. Neuraminidase inhibitors in influenza treatment and prevention: is it time to call it a day? Viruses. 2018;10(9):454.","journal-title":"Viruses"},{"issue":"10","key":"354_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/cid\/cix127","volume":"64","author":"S Venkatesan","year":"2017","unstructured":"Venkatesan S, Myles PR, Leonardi-Bee J, et al. Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an individual participant data metaanalysis. Clin Infect Dis. 2017;64(10):1328\u201334.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"354_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","volume":"2","author":"SG Muthuri","year":"2014","unstructured":"Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395\u2013404.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"354_CR25","first-page":"417","volume":"13","author":"MG Ison","year":"2015","unstructured":"Ison MG. Optimizing antiviral therapy for influenza: understanding the evidence. Expert Rev Anti Infect Ther. 2015;13(4):417\u201325.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"354_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fmed.2019.00109","volume":"6","author":"N Principi","year":"2019","unstructured":"Principi N, Camilloni B, Alunno A, Polinori I, Argentiero A, Esposito S. Drugs for influenza treatment: is there significant news? Front Med (Lausanne). 2019;6:109.","journal-title":"Front Med (Lausanne)"},{"key":"354_CR27","unstructured":"Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. 2018. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm. Accessed Nov 21, 2018."},{"issue":"2","key":"354_CR28","first-page":"CD010406","volume":"2","author":"L Lansbury","year":"2019","unstructured":"Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2019;2(2):CD010406.","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"354_CR29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.15585\/mmwr.mm6824a3","volume":"68","author":"X Xu","year":"2019","unstructured":"Xu X, Blanton L, Elal AIA, et al. Update: influenza activity in the United States during the 2018\u201319 season and composition of the 2019\u201320 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2019;68(24):544\u201351.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"354_CR30","unstructured":"Fingar K, Liang L, Stocks C. HCUP Statistical Brief #253. Inpatient hospital stays and emergency department visits involving influenza, 2006\u20132016. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb253-Influenza-Hospitalizations-ED-Visits-2006-2016.jsp#:~:text=During%2520this%2520flu%2520season%2C%25207%2C500,inpatient%2520stays%2520involving%2520the%2520flu. Accessed 17 Apr 2019."},{"key":"354_CR31","unstructured":"Kaiser Family Foundation. Distribution of Medicare beneficiaries by gender. 2018. https:\/\/www.kff.org\/medicare\/state-indicator\/medicare-beneficiaries-by-gender\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed 17 Apr 2019."},{"issue":"2","key":"354_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179\u201386.","journal-title":"JAMA"},{"issue":"27","key":"354_CR33","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","volume":"25","author":"NAM Molinari","year":"2007","unstructured":"Molinari NAM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086\u201396.","journal-title":"Vaccine"},{"issue":"5","key":"354_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.vaccine.2006.09.041","volume":"25","author":"JP Mullooly","year":"2007","unstructured":"Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25(5):846\u201355.","journal-title":"Vaccine"},{"key":"354_CR35","doi-asserted-by":"crossref","unstructured":"Choi WS, Baek JH, Seo YB, et al. Severe influenza treatment guideline. Korean J Intern Med. 2014;29(1):132\u201347.","DOI":"10.3904\/kjim.2014.29.1.132"},{"key":"354_CR36","unstructured":"Public Health England. PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza. 2019. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/773369\/PHE_guidance_antivirals_influenza.pdf. Accessed Apr 17, 2019."},{"issue":"8","key":"354_CR37","doi-asserted-by":"publisher","first-page":"e0134928","DOI":"10.1371\/journal.pone.0134928","volume":"10","author":"RD Pockett","year":"2015","unstructured":"Pockett RD, Watkins J, McEwan P, Meier G. Burden of illness in UK subjects with reported respiratory infections vaccinated or unvaccinated against influenza: a retrospective observational study. PLoS One. 2015;10(8):e0134928.","journal-title":"PLoS One"},{"issue":"4 suppl","key":"354_CR38","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/CCM.0b013e3181c92eeb","volume":"38","author":"MB Rothberg","year":"2010","unstructured":"Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2010;38(4 suppl):e91\u2013e9797.","journal-title":"Crit Care Med"},{"issue":"4","key":"354_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.amjmed.2007.10.040","volume":"121","author":"MB Rothberg","year":"2008","unstructured":"Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258\u201364.","journal-title":"Am J Med"},{"key":"354_CR40","first-page":"356","volume":"22","author":"S Venkatesan","year":"2020","unstructured":"Venkatesan S, Myles PR, Bolton KJ, et al. Neuraminidase inhibitors and hospital length of stay: a meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with nonfatal 2009 pandemic influenza A(H1N1) virus infection. J Infect Dis. 2020;22:356\u201366.","journal-title":"J Infect Dis"},{"issue":"7","key":"354_CR41","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10096-020-03835-6","volume":"39","author":"L Chen","year":"2020","unstructured":"Chen L, Han X, Li Y, Zhang C, Xing X. Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study. Eur J Clin Microbiol Infect Dis. 2020;39(7):1231\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"354_CR42","unstructured":"National Foundation for Infectious Diseases. Flu in adults age 65 years and older: what are the risks? 2018. https:\/\/www.adultvaccination.org\/vpd\/influenza\/influenza-65-infographic. Accessed Nov 21, 2018."},{"issue":"14","key":"354_CR43","doi-asserted-by":"publisher","first-page":"30506","DOI":"10.2807\/1560-7917.ES.2017.22.14.30506","volume":"22","author":"LS Vestergaard","year":"2017","unstructured":"Vestergaard LS, Nielsen J, Krause TG, et al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017;22(14):30506.","journal-title":"Euro Surveill"},{"key":"354_CR44","doi-asserted-by":"crossref","unstructured":"v d Hoeven AM, Scholing M, Wever PC, Fijnheer R, Hermans M, Schneeberger PM. Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection. 2007;35(2):65\u201368.","DOI":"10.1007\/s15010-007-6112-1"},{"issue":"6","key":"354_CR45","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.ajem.2015.03.008","volume":"33","author":"AF Dugas","year":"2015","unstructured":"Dugas AF, Valsamakis A, Atreya MR, et al. Clinical diagnosis of influenza in the ED. Am J Emerg Med. 2015;33(6):770\u20135.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"354_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7883\/yoken.JJID.2016.210","volume":"70","author":"D Dimitrijevi\u0107","year":"2017","unstructured":"Dimitrijevi\u0107 D, Ili\u0107 D, Raki\u0107 Adrovi\u0107 S, et al. Predictors of hospitalization and admission to intensive care units of influenza patients in Serbia through four influenza seasons from 2010\/2011 to 2013\/2014. Jpn J Infect Dis. 2017;70(3):275\u201383.","journal-title":"Jpn J Infect Dis"},{"issue":"21","key":"354_CR47","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1001\/jama.1994.03520210045030","volume":"272","author":"TME Govaert","year":"1994","unstructured":"Govaert TME, Thijs CTM, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661\u20135.","journal-title":"JAMA"},{"key":"354_CR48","unstructured":"Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases. The flu: caring for someone sick at home (2010). Policy brief. https:\/\/www.cdc.gov\/flu\/pdf\/freeresources\/general\/influenza_flu_homecare_guide.pdf."},{"issue":"9979","key":"354_CR49","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","volume":"385","author":"J Dobson","year":"2015","unstructured":"Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729\u201337.","journal-title":"Lancet"},{"key":"354_CR50","first-page":"CD00965","volume":"4","author":"T Jefferson","year":"2014","unstructured":"Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD00965.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"354_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2213-2600(16)30435-0","volume":"5","author":"FM Marty","year":"2017","unstructured":"Marty FM, Vidal-Puigserver J, Clark C, et al. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017;5(2):135\u201346.","journal-title":"Lancet Respir Med"},{"issue":"10217","key":"354_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0140-6736(19)32982-4","volume":"395","author":"CC Butler","year":"2020","unstructured":"Butler CC, van der Velden AW, Bongard E, et al. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet. 2020;395(10217):42\u201352.","journal-title":"Lancet"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-020-00354-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T19:23:21Z","timestamp":1635276201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-020-00354-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1007\/s40121-020-00354-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}